Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.81 USD | +3.44% | +10.32% | -26.56% |
25/06 | Zevra Therapeutics, Inc. Expands Executive Leadership Team | CI |
04/06 | Zevra Therapeutics Files $350 Million Mixed-Shelf; Shares Fall After Hours | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.56% | 19Cr | |
+7.95% | 7.22TCr | |
+14.98% | 914.1Cr | |
-24.60% | 433.23Cr | |
+15.26% | 427.89Cr | |
+28.46% | 415.25Cr | |
+7.76% | 219.31Cr | |
-35.98% | 197.84Cr | |
+7.76% | 197.5Cr | |
-47.71% | 167.89Cr |
- Stock Market
- Equities
- ZVRA Stock
- News Zevra Therapeutics, Inc.
- Transcript : Acer Therapeutics Inc., Zevra Therapeutics, Inc. - M&A Call